JP2016500821A5 - - Google Patents

Info

Publication number

JP2016500821A5

JP2016500821A5 JP2015538478A JP2015538478A JP2016500821A5 JP 2016500821 A5 JP2016500821 A5 JP 2016500821A5 JP 2015538478 A JP2015538478 A JP 2015538478A JP 2015538478 A JP2015538478 A JP 2015538478A JP 2016500821 A5 JP2016500821 A5 JP 2016500821A5

Authority

JP

Japan

Prior art keywords

cancer

production

patient

level

vitro method

Prior art date

2013-10-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 claims 104
• 206010028980 Neoplasm Diseases 0.000 claims 33
• 238000000034 method Methods 0.000 claims 32
• 201000011510 cancer Diseases 0.000 claims 30
• 238000004519 manufacturing process Methods 0.000 claims 29
• 238000000338 in vitro Methods 0.000 claims 24
• 239000012472 biological sample Substances 0.000 claims 18
• 206010006895 Cachexia Diseases 0.000 claims 14
• 206010012601 diabetes mellitus Diseases 0.000 claims 6
• 238000011282 treatment Methods 0.000 claims 6
• 210000004027 cell Anatomy 0.000 claims 5
• 238000001514 detection method Methods 0.000 claims 5
• 239000000523 sample Substances 0.000 claims 5
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
• 239000008280 blood Substances 0.000 claims 4
• 210000004369 blood Anatomy 0.000 claims 4
• 210000003722 extracellular fluid Anatomy 0.000 claims 4
• 239000008103 glucose Substances 0.000 claims 4
• 238000012544 monitoring process Methods 0.000 claims 4
• 241001465754 Metazoa Species 0.000 claims 3
• 238000011394 anticancer treatment Methods 0.000 claims 3
• 238000003745 diagnosis Methods 0.000 claims 3
• 201000010099 disease Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 238000004949 mass spectrometry Methods 0.000 claims 3
• 238000000074 matrix-assisted laser desorption--ionisation tandem time-of-flight detection Methods 0.000 claims 3
• 239000000126 substance Substances 0.000 claims 3
• 230000001225 therapeutic effect Effects 0.000 claims 3
• 210000001519 tissue Anatomy 0.000 claims 3
• 230000035899 viability Effects 0.000 claims 3
• 238000011319 anticancer therapy Methods 0.000 claims 2
• 230000001900 immune effect Effects 0.000 claims 2
• 238000011065 in-situ storage Methods 0.000 claims 2
• 230000004054 inflammatory process Effects 0.000 claims 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
• 230000000069 prophylactic effect Effects 0.000 claims 2
• 238000012216 screening Methods 0.000 claims 2
• 208000024891 symptom Diseases 0.000 claims 2
• 208000003174 Brain Neoplasms Diseases 0.000 claims 1
• 238000002965 ELISA Methods 0.000 claims 1
• 102000004877 Insulin Human genes 0.000 claims 1
• 108090001061 Insulin Proteins 0.000 claims 1
• 206010025323 Lymphomas Diseases 0.000 claims 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
• 206010039491 Sarcoma Diseases 0.000 claims 1
• 239000002671 adjuvant Substances 0.000 claims 1
• 238000004458 analytical method Methods 0.000 claims 1
• 238000003149 assay kit Methods 0.000 claims 1
• 210000000481 breast Anatomy 0.000 claims 1
• 238000012512 characterization method Methods 0.000 claims 1
• 239000003153 chemical reaction reagent Substances 0.000 claims 1
• 238000007705 chemical test Methods 0.000 claims 1
• 208000011654 childhood malignant neoplasm Diseases 0.000 claims 1
• 239000013068 control sample Substances 0.000 claims 1
• 230000002950 deficient Effects 0.000 claims 1
• 230000004069 differentiation Effects 0.000 claims 1
• 210000002249 digestive system Anatomy 0.000 claims 1
• 238000011156 evaluation Methods 0.000 claims 1
• 230000009229 glucose formation Effects 0.000 claims 1
• 230000002641 glycemic effect Effects 0.000 claims 1
• 210000003128 head Anatomy 0.000 claims 1
• 229940125396 insulin Drugs 0.000 claims 1
• 230000003914 insulin secretion Effects 0.000 claims 1
• 208000032839 leukemia Diseases 0.000 claims 1
• 210000004072 lung Anatomy 0.000 claims 1
• 230000003211 malignant effect Effects 0.000 claims 1
• 238000005259 measurement Methods 0.000 claims 1
• 201000001441 melanoma Diseases 0.000 claims 1
• 210000003739 neck Anatomy 0.000 claims 1
• 230000001019 normoglycemic effect Effects 0.000 claims 1
• 210000001672 ovary Anatomy 0.000 claims 1
• 210000002307 prostate Anatomy 0.000 claims 1
• 230000004044 response Effects 0.000 claims 1
• 238000004007 reversed phase HPLC Methods 0.000 claims 1
• 230000004083 survival effect Effects 0.000 claims 1
• 230000002123 temporal effect Effects 0.000 claims 1
• 238000012360 testing method Methods 0.000 claims 1
• 210000004291 uterus Anatomy 0.000 claims 1